MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaughan, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaughan, R. A.

Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping

RA Vaughan

Neuroscience Branch, National Institute on Drug Abuse Addiction Research Center, Baltimore, Maryland 21224, USA.

Binding domains on rat dopamine transporters for cocaine and 1-(2- diphenylmethoxy)ethyl-4-(3-phenylpropyl)piperazine compounds were identified using controlled proteolysis of photoaffinity-labeled protein and epitope-specific immunoprecipitation of the labeled fragments. Rat dopamine transporters were photoaffinity labeled with 1- [2-(diphenylmethoxy)ethyl]-4-[2-(4-azido- 3- [125I]iodophenyl)ethyl]piperazine ([125I]DEEP) [a 1-(2-di- phenylmethoxy)ethyl-4-(3-phenylpropyl)piperazine analog] or 3 beta-(p- chlorophenyl)tropane-2 beta-carboxylic acid, 4'-azido-3'- [125I]iodophenylethyl ester ([125I]RTI 82) (a cocaine analog) and were gel purified to remove contaminating radioactivity. The resulting samples were treated with V8 protease or trypsin and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The peptide maps generated with each enzyme were different for each of the ligands, suggesting that the ligands were incorporated into different regions of the protein. Identical peptide maps were generated from striatum- and nucleus accumbens-derived transporters, indicating that these polypeptides are highly similar in primary sequence. The proteolytic fragments generated by V8 protease were localized to specific domains of the protein using antipeptide antibodies corresponding to five different regions of the transporter. Fragments of 10 and 7 kDa from [125I]DEEP-labeled transporters were specifically immunoprecipitated with an antibody generated against amino acids 42-59 (near the first putative trans-membrane domain), whereas a 34-kDa fragment from [125I]RTI 82-labeled transporters was precipitated with three different sera corresponding to regions in the carboxyl-terminal two thirds of the protein. None of the V8 fragments smaller than 45 kDa, containing either photolabel, was altered in molecular mass by N-deglycosylation. The results indicate that photoincorporation of [125I]DEEP occurs in the amino half of the dopamine transporter, near the first two transmembrane helices, whereas [125I]RTI 82 labels the carboxyl- terminal region of the protein, between transmembrane domains 4 and 12.

Volume 47, Issue 5, pp. 956-964, 05/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. L. Parnas, J. D. Gaffaney, M. F. Zou, J. R. Lever, A. H. Newman, and R. A. Vaughan
Labeling of Dopamine Transporter Transmembrane Domain 1 with the Tropane Ligand N-[4-(4-Azido-3-[125I]iodophenyl)butyl]-2{beta}-carbomethoxy-3{beta}-(4-chlorophenyl)tropane Implicates Proximity of Cocaine and Substrate Active Sites
Mol. Pharmacol., April 1, 2008; 73(4): 1141 - 1150.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Vaughan, D. S. Sakrikar, M. L. Parnas, S. Adkins, J. D. Foster, R. A. Duval, J. R. Lever, S. S. Kulkarni, and A. Hauck-Newman
Localization of Cocaine Analog [125I]RTI 82 Irreversible Binding to Transmembrane Domain 6 of the Dopamine Transporter
J. Biol. Chem., March 23, 2007; 282(12): 8915 - 8925.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. D. Gaffaney and R. A. Vaughan
Uptake Inhibitors but not Substrates Induce Protease Resistance in Extracellular Loop Two of the Dopamine Transporter
Mol. Pharmacol., March 1, 2004; 65(3): 692 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Foster, B. Pananusorn, and R. A. Vaughan
Dopamine Transporters Are Phosphorylated on N-terminal Serines in Rat Striatum
J. Biol. Chem., July 5, 2002; 277(28): 25178 - 25186.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Vaughan, J. D. Gaffaney, J. R. Lever, M. E. A. Reith, and A. K. Dutta
Dual Incorporation of Photoaffinity Ligands on Dopamine Transporters Implicates Proximity of Labeled Domains
Mol. Pharmacol., April 16, 2001; 59(5): 1157 - 1164.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. J. Eshleman, K. Wolfrum, D. C. Mash, K. Christensen, and A. Janowsky
Drug Interactions with the Dopamine Transporter in Cryopreserved Human Caudate
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 442 - 449.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
R. A. Vaughan, G. E. Agoston, J. R. Lever, and A. H. Newman
Differential Binding of Tropane-Based Photoaffinity Ligands on the Dopamine Transporter
J. Neurosci., January 15, 1999; 19(2): 630 - 636.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Barker, M. A. Perlman, E. M. Adkins, W. J. Houlihan, Z. B. Pristupa, H. B. Niznik, and R. D. Blakely
High Affinity Recognition of Serotonin Transporter Antagonists Defined by Species-scanning Mutagenesis. AN AROMATIC RESIDUE IN TRANSMEMBRANE DOMAIN I DICTATES SPECIES-SELECTIVE RECOGNITION OF CITALOPRAM AND MAZINDOL
J. Biol. Chem., July 31, 1998; 273(31): 19459 - 19468.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Tirelli, B. Geter-Douglass, and J. M. Witkin
gamma -Aminobutyric AcidA Agonists Differentially Augment Gnawing Induced by Indirect-Acting Dopamine Agonists in C57BL/6J Mice
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 116 - 124.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. A. Vaughan, R. A. Huff, G. R. Uhl, and M. J. Kuhar
Protein Kinase C-mediated Phosphorylation and Functional Regulation of Dopamine Transporters in Striatal Synaptosomes
J. Biol. Chem., June 13, 1997; 272(24): 15541 - 15546.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Vaughan and M. J. Kuhar
Dopamine Transporter Ligand Binding Domains. STRUCTURAL AND FUNCTIONAL PROPERTIES REVEALED BY LIMITED PROTEOLYSIS
J. Biol. Chem., August 30, 1996; 271(35): 21672 - 21680.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. J.S. Lee, Z. B. Pristupa, B. J. Ciliax, A. I. Levey, and H. B. Niznik
The Dopamine Transporter Carboxyl-terminal Tail. TRUNCATION/SUBSTITUTION MUTANTS SELECTIVELY CONFER HIGH AFFINITY DOPAMINE UPTAKE WHILE ATTENUATING RECOGNITION OF THE LIGAND BINDING DOMAIN
J. Biol. Chem., August 23, 1996; 271(34): 20885 - 20894.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. G. F. Rasmussen, F. I. Carroll, M. J. Maresch, A. D. Jensen, C. G. Tate, and U. Gether
Biophysical Characterization of the Cocaine Binding Pocket in the Serotonin Transporter Using a Fluorescent Cocaine Analogue as a Molecular Reporter
J. Biol. Chem., February 9, 2001; 276(7): 4717 - 4723.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics